NCT00037661View on ClinicalTrials.gov

Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye

PHASE3CompletedINTERVENTIONAL
Enrollment

222

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

March 31, 2003

Study Completion Date

March 31, 2003

Conditions
Keratoconjunctivitis Sicca
Interventions
DRUG

INS365 Ophthalmic Solution

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00037661 - Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye | Biotech Hunter | Biotech Hunter